Investing

Opening Bell Analysts Research Calls for Tuesday, December 13

Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today. 

Research calls posted earlier this morning are available here.  

Upgrades:

> First Hawaiian (FHB) upgraded to Neutral from Underweight at JP Morgan; tgt $26

> Molina Healthcare (MOH) upgraded to Neutral from Underperform at BofA Securities; tgt $388

> Pinterest (PINS) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $30

> Pfizer (PFE) upgraded to Buy from Neutral at Goldman; tgt raised to $60

> Playtika (PLTK) upgraded to Neutral from Underperform at BofA Securities; tgt $9

Downgrades:

> Centene (CNC) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $85

> easyJet (ESYJY) downgraded to Sell from Hold at Deutsche Bank

> KeyCorp (KEY) downgraded to Underweight from Neutral at JP Morgan; tgt lowered to $17

> Live Oak Bancshares (LOB) downgraded to Underweight from Neutral at JP Morgan; tgt lowered to $30

> MultiPlan (MPLN) downgraded to Neutral from Buy at Citigroup; tgt lowered to $2

> NetApp (NTAP) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt lowered to $58

> Norwegian Cruise Line (NCLH) downgraded to Neutral from Buy at UBS; tgt lowered to $19

> nVent Electric (NVT) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets

> Petrobras (PBR) downgraded to Neutral from Outperform at Bradesco BBI

> Premier Financial (PFC) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt $32

> Rio Tinto (RIO) downgraded to Sell from Neutral at UBS

> Sabra Health Care REIT (SBRA) downgraded to Mkt Perform from Mkt Outperform at JMP Securities

> Synchrony Financial (SYF) downgraded to Neutral from Buy at BofA Securities

> Trimble (TRMB) downgraded to Mkt Perform from Outperform at Raymond James

> TriplePoint Venture Growth (TPVG) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $13.50

Others:

> Adyen (ADYYF) with a Buy at Jefferies

> Arcellx (ACLX) resumed with a Buy at BofA Securities; tgt raised to $37

> ARS Pharmaceuticals (SPRY) initiated with an Outperform at SVB Leerink; tgt $14

> FormFactor (FORM) initiated with an Outperform at Northland Capital; tgt $33

> Gilead Sciences (GILD) resumed with a Neutral at BofA Securities; tgt $85

> Jabil (JBL) initiated with a Neutral at UBS; tgt $76

> Lumentum (LITE) initiated with a Neutral at UBS; tgt $50

> Mondee Holdings (MOND) initiated with a Buy at ROTH Capital; tgt $12

> MSCI (MSCI) initiated with an Overweight at JP Morgan; tgt $580

> Okta (OKTA) initiated with a Market Perform at Cowen; tgt $70

> Opendoor Technologies (OPEN) initiated with a Neutral at Citigroup; tgt $1.50

> PayPal (PYPL) assumed with a Neutral at Piper Sandler; tgt $85

> Sanofi (SNY) resumed with an Overweight at Morgan Stanley

> SIGNA Sports United (SSU) initiated with a Neutral at Citigroup; tgt $6.20

> Squarespace (SQSP) initiated with a Neutral at Citigroup; tgt $21

> SunPower (SPWR) initiated with a Peer Perform at Wolfe Research

> UMH Properties (UMH) initiated with a Buy at EF Hutton; tgt $21

> Zillow (ZG) assumed with a Buy at Citigroup; tgt $50

Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)

If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.

Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.